Cecilia Brown is an assistant editor for Mashup Media, the parent company of GU Oncology Now. Cecilia is a medical writer and editor with over four years of experience in publishing and journalism, as well as several years of research experience. She can be reached at CBrown@mashupmd.com.
The pretreatment albumin-globulin ratio can independently predict survival outcomes in patients with urothelial carcinoma.
Researchers identified the top reason why some patients with urothelial carcinoma don't pursue treatment.
Shilpa Gupta, MD, discusses recent developments in targeted molecular therapeutics for advanced bladder cancer.
Enfortumab vedotin plus pembrolizumab led to an ORR of 73.3% in cisplatin-ineligible patients with urothelial cancer.
Dr. Mary Beth Westerman, speaks on notable advances that she has see in bladder cancer throughout her career.
Dr. Westerman speaks on what clinicians can do to improve pre-operative counseling for female patients with bladder cancer.
Dr. Mary Beth Westerman provides insight on some of the main challenges in treating women with bladder cancer.
Renal Cell Carcinoma | August 26, 2022
Treatment with an ICI plus a VEGF receptor inhibitor showed increased likelihood of obtaining an objective imaging response.
Prostate Cancer | August 16, 2022
Failure-free survival rates between focal cryoablation and stereotactic body radiotherapy for prostate cancer no different.